|
1
|
Baade PD, Youlden DR and Krnjacki LJ:
International epidemiology of prostate cancer: geographical
distribution and secular trends. Mol Nutr Food Res. 53:171–184.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Majumdar S, Buckles E, Estrada J and
Koochekpour S: Aberrant DNA methylation and prostate cancer. Curr
Genomics. 12:486–505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Formosa A, Lena AM, Markert EK, et al: DNA
methylation silences miR-132 in prostate cancer. Oncogene.
32:127–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sotiropoulou G, Pampalakis G, Lianidou E
and Mourelatos Z: Emerging roles of microRNAs as molecular switches
in the integrated circuit of the cancer cell. RNA. 15:1443–1461.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang YX and Gao WQ: Roles of microRNAs
during prostatic tumorigenesis and tumor progression. Oncogene. Mar
4–2013.(Epub ahead of print).
|
|
8
|
Komatsu S, Ichikawa D, Takeshita H, et al:
Circulating microRNAs in plasma of patients with oesophageal
squamous cell carcinoma. Br J Cancer. 105:104–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lajer CB, Nielsen FC, Friis-Hansen L, et
al: Different miRNA signatures of oral and pharyngeal squamous cell
carcinomas: a prospective translational study. Br J Cancer.
104:830–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takeshita K, Suetake I, Yamashita E, et
al: Structural insight into maintenance methylation by mouse DNA
methyltransferase 1 (Dnmt1). Proc Natl Acad Sci USA. 108:9055–9059.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Basu A, Alder H, Khiyami A, Leahy P, Croce
CM and Haldar S: MicroRNA-375 and microRNA-221: potential noncoding
RNAs associated with antiproliferative activity of benzyl
isothiocyanate in pancreatic cancer. Genes Cancer. 2:108–119. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu AM, Poon RT and Luk JM: MicroRNA-375
targets Hippo-signaling effector YAP in liver cancer and inhibits
tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mazar J, DeBlasio D, Govindarajan SS,
Zhang S and Perera RJ: Epigenetic regulation of microRNA-375 and
its role in melanoma development in humans. FEBS Lett.
585:2467–2476. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang F, Li Y, Zhou J, et al: miR-375 is
down-regulated in squamous cervical cancer and inhibits cell
migration and invasion via targeting transcription factor SP1. Am J
Pathol. 179:2580–2588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nohata N, Hanazawa T, Kikkawa N, et al:
Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in
head and neck squamous cell carcinoma (HNSCC). J Hum Genet.
56:595–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szczyrba J, Nolte E, Wach S, et al:
Downregulation of Sec23A protein by miRNA-375 in prostate
carcinoma. Mol Cancer Res. 9:791–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simonini PdSR, Breiling A, Gupta N, et al:
Epigenetically deregulated microRNA-375 is involved in a positive
feedback loop with estrogen receptor α in breast cancer cells.
Cancer Res. 70:9175–9184. 2010.PubMed/NCBI
|
|
18
|
Shibata A and Minn AY: Perinatal sex
hormones and risk of breast and prostate cancers in adulthood.
Epidemiol Rev. 22:239–248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heinlein CA and Chang C: Androgen receptor
in prostate cancer. Endocr Rev. 25:276–308. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Le Dai J, Maiorino CA, Gkonos PJ and
Burnstein KL: Androgenic up-regulation of androgen receptor cDNA
expression in androgen-independent prostate cancer cells. Steroids.
61:531–539. 1996.PubMed/NCBI
|
|
21
|
Guo Z and Qiu Y: A new trick of an old
molecule: androgen receptor splice variants taking the stage?! Int
J Biol Sci. 7:815–822. 2011.PubMed/NCBI
|
|
22
|
Li L-C and Dahiya R: MethPrimer: designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Whitbread AK, Veveris-Lowe TL, Lawrence
MG, Nicol DL and Clements JA: The role of kallikrein-related
peptidases in prostate cancer: potential involvement in an
epithelial to mesenchymal transition. Biol Chem. 387:707–714. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gregory CW, Hamil KG, Kim D, et al:
Androgen receptor expression in androgen-independent prostate
cancer is associated with increased expression of
androgen-regulated genes. Cancer Res. 58:5718–5724. 1998.PubMed/NCBI
|
|
25
|
Xu LL, Shi Y, Petrovics G, et al: PMEPA1,
an androgen-regulated NEDD4-binding protein, exhibits cell growth
inhibitory function and decreased expression during prostate cancer
progression. Cancer Res. 63:4299–4304. 2003.
|
|
26
|
Gnanapragasam VJ, Robson CN, Neal DE and
Leung HY: Regulation of FGF8 expression by the androgen receptor in
human prostate cancer. Oncogene. 21:5069–5080. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin B, Ferguson C, White JT, et al:
Prostate-localized and androgen-regulated expression of the
membrane-bound serine protease TMPRSS2. Cancer Res. 59:4180–4184.
1999.PubMed/NCBI
|
|
28
|
Yoo J and Medina-Franco JL: Discovery and
optimization of inhibitors of DNA methyltransferase as novel drugs
for cancer therapy. Drug Development - A Case Study Based Insight
into Modern Strategies. Rundfeldt C: InTech; pp. 3–22. 2011
|
|
29
|
Majumder S, Ghoshal K, Datta J, et al:
Role of de novo DNA methyltransferases and methyl CpG-binding
proteins in gene silencing in a rat hepatoma. J Biol Chem.
277:16048–16058. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahluwalia A, Hurteau JA, Bigsby RM and
Nephew KP: DNA methylation in ovarian cancer: II. Expression of DNA
methyltransferases in ovarian cancer cell lines and normal ovarian
epithelial cells. Gynecol Oncol. 82:299–304. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin B, Yao B, Li J-L, et al: DNMT1 and
DNMT3B modulate distinct polycomb-mediated histone modifications in
colon cancer. Cancer Res. 69:7412–7421. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Patra SK, Patra A, Zhao H and Dahiya R:
DNA methyltransferase and demethylase in human prostate cancer. Mol
Carcinogen. 33:163–171. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Okano M, Bell DW, Haber DA and Li E: DNA
methyltransferases Dnmt3a and Dnmt3b are essential for de novo
methylation and mammalian development. Cell. 99:247–257. 1999.
View Article : Google Scholar : PubMed/NCBI
|
